A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC

NCT00369070 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non-squamous NSCLC

Interventions

BIOLOGICAL: Bevacizumab
DRUG: AMG 706
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Amgen